NOVA T4
NOVA‑T4 Tablet by NovaTech Sciences contains Levothyroxine Sodium (CAS 51‑48‑9). Trusted manufacturer, supplier, and exporter of pharmaceutical‑grade thyroid support for hormone balance and metabolic health.
CAS Number: 55-03-8
NOVA T4 (Levothyroxine Sodium T4 50 mcg) is indicated for individuals requiring thyroid hormone replacement or supplementation. It helps maintain stable metabolism, energy, and overall hormonal balance. Often used alongside steroid cycles or performance regimens, NOVA T4 supports metabolic stability and thyroid function under medical supervision.
NOVA-T4 by Nova Techsciences is presented as an oral tablet containing Levothyroxine Sodium 50 mcg. Levothyroxine Sodium is a synthetic form of thyroxine, commonly called T4, and is identified by CAS Number 55-03-8. It replaces or supplements thyroid hormone when the thyroid gland cannot produce an adequate amount naturally.
Levothyroxine is an established prescription medicine used in the management of hypothyroidism and certain other thyroid-related conditions. Treatment must be individually assessed because thyroid-hormone requirements vary between patients and can be affected by age, medical history, pregnancy, other medicines and laboratory findings.
NOVA-T4 Product Overview
- Product name: NOVA-T4
- Active compound: Levothyroxine Sodium
- Strength: 50 mcg per tablet
- Dosage form: Oral tablet
- CAS Number: 55-03-8
- Brand: Nova Techsciences
The NOVA-T4 label should identify the complete formulation, excipients, tablet quantity, storage requirements, batch number, manufacturing date and expiry date. Information shown on the website should remain consistent with the packaging, Certificate of Analysis and applicable regulatory documents.
Quality Control and Traceability
Thyroid-hormone tablets require precise production controls because small variations in active-ingredient content may affect treatment. Suitable testing may include raw-material identification, active-compound assay, content uniformity, dissolution, impurity analysis, stability assessment and packaging-integrity checks.
Each NOVA-T4 batch should have a traceable identification number connected to its manufacturing and laboratory-release records. For the United Kingdom, Netherlands and other European markets, Nova Techsciences should clearly state the product’s marketing-authorisation status, prescription category, responsible manufacturer and adverse-event reporting process.
Safety and Responsible Use
Excessive thyroid-hormone exposure can produce symptoms associated with an overactive thyroid, including palpitations, rapid heartbeat, sweating, tremor, anxiety, sleep disturbance and unexplained weight loss. Levothyroxine also requires particular care in patients with cardiovascular disease, untreated adrenal insufficiency or long-standing hypothyroidism.
NOVA-T4 should not be presented as a general weight-loss, fat-burning, bodybuilding or metabolism-enhancement product. Patients should not start, stop or change thyroid treatment without professional guidance and appropriate thyroid-function monitoring.
Related Nova Techsciences Products
NOVABOL
NOVABOL contains Oxandrolone USP 10 mg, identified by CAS Number 53-39-4. It is an anabolic-androgenic compound rather than a thyroid medicine. Its page should provide separate information covering regulatory status, liver and cardiovascular precautions, contraindications, batch testing and warnings against non-medical use.
NOVAMETH
NOVAMETH contains Methandienone 10 mg, with CAS Number 72-63-9. Methandienone is an oral anabolic-androgenic steroid with a distinct safety profile. It requires clear liver, cardiovascular, hormonal and reproductive warnings and should not be presented as interchangeable with Levothyroxine Sodium.
NOVAMOREN
NOVAMOREN is presented as an MK-677 or Ibutamoren product, associated with CAS Number 159752-10-0. Ibutamoren is a growth-hormone secretagogue and is chemically different from thyroid hormones and anabolic steroids. Its legal status and supporting clinical evidence should be stated accurately.
NOVAZOLE
NOVAZOLE contains Anastrozole 1 mg, identified by CAS Number 120511-73-1. Anastrozole is an aromatase inhibitor used in authorised medical settings for specific hormone-dependent breast cancers. It has separate contraindications, bone-health considerations and prescribing requirements.
OXYDROL
OXYDROL contains Oxymetholone USP 50 mg, associated with CAS Number 434-07-1. Oxymetholone is an anabolic-androgenic medicine with significant liver, cardiovascular and hormonal risks. Its product page should prioritise regulatory status, contraindications, professional oversight and responsible safety communication.
NOVA-T4 should ultimately be presented through accurate compound identification, precise strength information, transparent batch documentation and balanced medical safety guidance.
Important Information & FAQs
Precautions & Contraindications
Precautions
- Always use NOVA T4 under medical supervision.
- Follow prescribed dosage; do not self-medicate.
- Inform your doctor of any steroid, supplement, or hormonal medication use.
- Avoid use in untreated adrenal insufficiency, acute myocardial infarction, uncontrolled hyperthyroidism, or serious cardiovascular disorders.
- Keep out of reach of children; store in a dry, cool place.
- Avoid alcohol or stimulant substances that may interfere with absorption.
- Monitor for rapid heartbeat, chest pain, extreme nervousness, or unusual sweating, and seek medical help if needed.
- Pregnant or breastfeeding women should consult a physician before use.
Contraindications
- Do not use if allergic to Levothyroxine or any inactive ingredients.
- Avoid self-medication or combining with steroids without medical supervision.
- Not suitable for untreated adrenal insufficiency or serious cardiovascular conditions.
- Discontinue and seek medical attention if unusual symptoms appear.
Related Products
AROMANOVA
High-potency Exemestane tablets for advanced estrogen control and PCT support.
CABERNOVA
Premium Cabergoline tablets for prolactin control, hormone support, and enhanced recovery.
CLOMINOVA
Clomiphene Citrate 50 mg tablets for post-cycle therapy, testosterone recovery, and hormonal balance.
ENCLOMINOVA
Premium Enclomiphene Citrate tablets for testosterone boosting, PCT recovery, and hormonal balance.